By NewsDesk  @bactiman63 Massachusetts based biotechnology company, Moderna, announced today that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196 cases confirms the high...

The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) today for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients as part of the...

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) today to enable emergency use of the Centers for Disease Control and Prevention’s (CDC) 2019-nCoV Real-Time RT-PCR...